Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

Abstract: In today's scenario, security threats are increasing day by day as technology. Security breaches not only affect financial loss but also affect the trustworthiness and integrity of the ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

Abstract: This study explores the degradation behavior of cable insulation under simulated aging conditions, specifically focusing on monitoring thermal properties. The insulations, used in nuclear ...